The nation of Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (£272m) spanning five years over Washington's insistence on confidential biological samples.
This rejection became public following a government memo from December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative has since stated that the US was demanding access to biological samples for scientific study and commercial purposes but was not willing to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for more dialogue to find a deal acceptable to all parties so the country's critical HIV programme can be sustained.
Broader Background
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement after legal challenges were raised about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had administered aid for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government deals to boost openness and accountability.
According to statements, Sixteen nations in Africa have so far agreed to similar agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our population if a new disease outbreak arise."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining frameworks previously set up through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This framework is intended to ensure that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent collaboration might be structured in a way that respects the independence and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that talks need to persist since much of the country's Aids initiatives relied on foreign aid.
"If technical issues arise, such as those relating to information security or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group commented.
The situation underscores the complex debate between accepting crucial foreign assistance and protecting local interests in an ever more data-driven world.